Siemens Races Toward Record High as Restructuring Plans and Infrastructure Boom Converge

Siemens stock rallies 16% from March low, nearing €261.55 record, driven by record €120B backlog, corporate overhaul, and planned Healthineers spin-off.

Siemens shares have staged a powerful recovery, climbing roughly 16% from their March low to trade near €252, and are now within striking distance of the all-time high of €261.55 set in January. The rally, which has seen the stock gain nearly 20% over the past month, reflects a confluence of factors: a surging DAX above 24,000 points, a structural boom in data centers and power grids, and a series of strategic moves that are reshaping Europe’s largest industrial conglomerate.

The momentum has been underpinned by robust operational performance. In the first quarter of fiscal 2026, group orders jumped 10% to €21.4 billion, while revenue rose 8% to €19.1 billion. The order backlog swelled to a record €120 billion. Industrial profit climbed 15% to €2.9 billion, with the Smart Infrastructure division alone booking over €7 billion in new orders. These figures prompted management to lift the full-year earnings forecast to a range of €10.70 to €11.10 per share, with revenue growth expected to land in the upper half of the 6% to 8% target band.

Behind the headline numbers, a far-reaching corporate overhaul is taking shape. CEO Roland Busch is pushing forward with his “One Tech Company” strategy, which aims to break down silos and tightly integrate infrastructure, transport, software, and artificial intelligence. As part of that plan, Siemens intends to dissolve its Digital Industries and Smart Infrastructure divisions and reorganize them into six or seven smaller units. The supervisory board and worker representatives are expected to discuss the restructuring in May 2026, though no final decision has been made and no job cuts are anticipated. The Mobility division, focused on rail technology, will remain untouched.

Parallel to the internal reorganization, Siemens is advancing the separation of its Healthineers medical technology unit. A shareholder vote on a direct spin-off is scheduled for the annual general meeting in February 2027. Under the plan, 30% of Healthineers shares would be transferred directly to Siemens shareholders under German transformation law. Regulatory clarifications are ongoing, and final approval is still pending. Siemens has committed to maintaining its progressive dividend policy even after the deconsolidation.

The restructuring push comes as analysts grow increasingly bullish on the stock. Bernstein Research has set a price target of €300 with an overweight rating, while UBS and Goldman Sachs also recommend buying, albeit with more conservative targets of €255 and €245, respectively. Goldman Sachs expects the organic growth momentum to remain strong when Siemens reports its second-quarter results on May 13, a date that should also shed light on the terms of the Healthineers spin-off.

On the production side, Siemens Mobility has opened a new €220 million facility in Lexington, North Carolina, its first in North America capable of overhauling both passenger cars and locomotives. The plant is expected to create more than 500 jobs by 2028, underscoring the company’s commitment to expanding its footprint in the U.S. infrastructure market.

In the broader analyst community, JPMorgan has maintained an overweight rating on Healthineers, noting that risks highlighted by competitor GE Healthcare’s recent results are largely priced into the stock. For Siemens itself, the average analyst price target stands at €268, with a consensus buy rating — a signal that the market sees further upside as the conglomerate navigates its most significant structural transformation in years.